| Eubacterium| Eubacterium Prevot 1938 (Approved Lists 1980) emend. Cato et al. 1983
Butyrate Production: Some species within the Eubacterium genus are known to produce butyrate, a short-chain fatty acid (SCFA) with beneficial effects on gut health. Butyrate is a crucial energy source for colonocytes (cells lining the colon) and plays a role in maintaining gut barrier integrity, reducing inflammation, and supporting overall gut health.
Fermentation and Metabolism: Eubacterium species contribute to the fermentation of dietary fibers and complex carbohydrates that are not digested by the human host. This fermentation process results in the production of SCFAs, including butyrate, acetate, and propionate, which can have positive effects on gut health and overall metabolism.
Gut Microbiota Balance: Eubacterium species are part of the complex microbial ecosystem in the gut. They play a role in maintaining a balanced and diverse gut microbiota, which is essential for overall gut health and immune function.
Influence on Immune Responses: Some research suggests that certain Eubacterium species may have immunomodulatory effects, contributing to the regulation of immune responses in the gut. This modulation of the immune system may help maintain gut homeostasis and support a balanced immune response.
Metabolic Health: While research is ongoing, some studies have suggested associations between the abundance of certain Eubacterium species and metabolic health markers, such as improved glucose metabolism and better lipid profiles. However, the specific mechanisms and direct impacts on metabolic health require further investigation.
Potential Impact on Disease States: Alterations in the abundance or diversity of Eubacterium species have been observed in various disease states, including inflammatory bowel diseases (IBD), obesity, and metabolic disorders. However, the exact role of Eubacterium in disease development or mitigation is still being studied.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 6.49 | 0 | 0 | 1 | 31273 | 0 | 54359 | 15747 | 10180 | 19700 | 0 | 39820 | 0 %ile | 92 %ile |
biomesight | 89.02 | 0 | 1950 | 50 | 18120 | 0 | 15276 | 2394.1 | 300 | 6572.3 | 0 | 3100 | 9.9 %ile | 97.6 %ile |
thorne | 100 | 180 | 762 | 110 | 753 | 431.3 | 439 | 164.1 | 105 | 681 | 0 %ile | 100 %ile | ||
thryve | 100 | 5892 | 72766 | 10468 | 59966 | 0 | 110085 | 39452.1 | 31282 | 36037 | 2785 | 71769 | 10.8 %ile | 90.8 %ile |
ubiome | 19.26 | 0 | 25 | 20 | 33180 | 0 | 7029 | 839.7 | 140 | 3157.6 | 0 | 662 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Metagenomics | 0 | 0 | 0 | 0 |
Jason Hawrelak | 0 | 150000 | 0 | 15 |
Lab Teletest | 500 | 3000 | 0.05 | 0.3 |
GanzImmun Diagostics | 2000 | 16000 | 0.2 | 1.6 |
Thorne (20/80%ile) | 2478.6 | 8269.6 | 0.2479 | 0.827 |
Medivere | 3000 | 23000 | 0.3 | 2.3 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 73.333 % | 0.047 % | 0.075 % | 11.0 | 15 |
Biomesight | 95.211 % | 0.25 % | 0.67 % | 2823.0 | 2965 |
BiomeSightRdp | 51.613 % | 0.114 % | 0.279 % | 16.0 | 31 |
bugspeak | 100 % | 1.189 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.075 % | 0.004 % | 3.0 | 3 |
CosmosId | 100 % | 1.961 % | 1.47 % | 32.0 | 32 |
custom | 40.984 % | 0.673 % | 1.191 % | 25.0 | 61 |
es-xenogene | 96.552 % | 1.094 % | 3.493 % | 28.0 | 29 |
GanzimmunDiag | 100 % | 6.976 % | 0 % | 3.0 | 3 |
Medivere | 100 % | 1.278 % | 0.995 % | 7.0 | 7 |
Microba | 82.143 % | 1.056 % | 0.816 % | 23.0 | 28 |
SequentiaBiotech | 100 % | 2.591 % | 1.085 % | 36.0 | 36 |
Thorne | 86.538 % | 0.135 % | 0.3 % | 90.0 | 104 |
Thryve | 100 % | 3.918 % | 3.489 % | 1392.0 | 1392 |
Tiny | 50 % | 0.001 % | % | 1.0 | 2 |
uBiome | 19.066 % | 0.084 % | 0.317 % | 151.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.